We narrowed to 5,990 results for: paav

1. pAAV-S5E2-GFP-fGFP (AAV9)

   Viral Prep

   #135631-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Promoter

   Tags

   EGFP

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-fDIO-mNeonGreen (AAV1)

   Viral Prep

   #99133-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-fDIO-mNeonGreen (#99133). In addition to the viral particles, you will also receive purified pAAV-CAG-fDIO-mNeonGreen plasmid DNA. CAG-driven, Flp-dependent mNeonGreen expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

   Promoter

   CAG

   Tags

   mNeonGreen (Flp-dependent)

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-S5E2-ChR2-mCherry (AAV9)

   Viral Prep

   #135634-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Promoter

   Tags

   mCherry

   Available Since

   Sept. 15, 2021

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-hSyn-EGFP (AAV5 trial size)

   Viral Prep

   #50465-AAV5.T

   Purpose

   Ready-to-use AAV5 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   June 12, 2019

   Availability

   Academic Institutions and Nonprofits only

5. pAAV_hSyn-PdCO-EGFP-WPRE (AAV1)

   Viral Prep

   #198513-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_hSyn-PdCO-EGFP-WPRE (#198513). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-EGFP-WPRE plasmid DNA. Synapsin-driven expression of the optimized opsin PdCO in frame with EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ofer Yizhar

   Article

   Wietek et al Nat Methods. 2024 May 29. doi: 10.1038/s

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   April 10, 2024

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-hSynapsin1-axon-GCaMP6m (AAV9)

   Viral Prep

   #111261-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-axon-GCaMP6m (#111261). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-GCaMP6m plasmid DNA. Synapsin-driven expression of calcium sensor GCaMP6m in axons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Lin Tian

   Article

   Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

   Promoter

   Syn

   Tags

   None

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-CAG-iSeroSnFR-Nlgn (AAV9)

   Viral Prep

   #128485-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CAG-iSeroSnFR-Nlgn (#128485). In addition to the viral particles, you will also receive purified pAAV-CAG-iSeroSnFR-Nlgn plasmid DNA. CAG-driven expression of a fluorescent reporter for serotonin (localized to dendrites). These AAV preparations are suitable purity for injection into animals.

   Depositor

   Lin Tian

   Article

   Unger et al Cell. 2020 Dec 12. pii: S0092-8674(20)31

   Promoter

   CAG

   Tags

   None

   Available Since

   Feb. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-hSyn-JEDI-2P-Kv-WPRE (AAV9)

   Viral Prep

   #179463-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSyn-JEDI-2P-Kv-WPRE (#179463). In addition to the viral particles, you will also receive purified pAAV-hSyn-JEDI-2P-Kv-WPRE plasmid DNA. hSyn-driven expression (soma and AIS-localized) of the genetically encoded voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Francois St-Pierre

   Article

   Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

   Promoter

   Syn

   Tags

   None

   Available Since

   Jan. 24, 2024

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-hIBA1a-GFP-miR124T (AAV5)

   Viral Prep

   #214147-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-hIBA1a-GFP-miR124T (#214147). In addition to the viral particles, you will also receive purified pAAV-hIBA1a-GFP-miR124T plasmid DNA. hIBA1a-driven and miR124T-targeted for microglial inhibition of GFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Chun-Li Zhang

   Article

   Serrano et al iScience. 2024 Aug 12;27(9):110706. doi:

   Promoter

   Tags

   GFP

   Available Since

   Sept. 22, 2025

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CAG-FLEX-EGFP (AAV1)

    Viral Prep

    #59331-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-CAG-FLEX-EGFP (#59331). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-EGFP plasmid DNA. CAG-driven, Cre-dependent expression of EGFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ian Wickersham

    Promoter

    CAG

    Tags

    EGFP

    Available Since

    July 12, 2023

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-Ef1a-DIO EYFP (AAV2)

    Viral Prep

    #27056-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    Tags

    EYFP (Cre-dependent)

    Available Since

    Feb. 15, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hsyn-GRAB_DA-mut (AAV9)

    Viral Prep

    #140555-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hsyn-GRAB_DA-mut (#140555). In addition to the viral particles, you will also receive purified pAAV-hsyn-GRAB_DA-mut plasmid DNA. Synapsin-driven expression of control dopamine sensor GRAB_DA-mut (does not respond to DA). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Yulong Li

    Article

    Sun et al Nat Methods. 2020 Nov;17(11):1156-1166.

    Promoter

    Syn

    Tags

    None

    Available Since

    Aug. 31, 2021

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-Syn-Chronos-tdTomato (AAV8)

    Viral Prep

    #62726-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Syn-Chronos-tdTomato (#62726). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-tdTomato plasmid DNA. Syn-driven Chronos-tdTomato expression for optogenetic neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    Syn

    Tags

    tdTomato

    Available Since

    Feb. 7, 2018

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-FLEX-P301L Tau (AAV1)

    Viral Prep

    #176267-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-FLEX-P301L Tau (#176267). In addition to the viral particles, you will also receive purified pAAV-FLEX-P301L Tau plasmid DNA. EF1a-driven, Cre-dependent expression of human 2N4R microtubule-associated protein tau with P301L mutation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Tsuneya Ikezu

    Article

    You et al Neuroscience. 2019 Dec 1;422:65-74. doi:

    Promoter

    Tags

    None

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-Ef1a-fDIO mCherry (AAV2)

    Viral Prep

    #114471-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-Ef1a-fDIO mCherry (#114471). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO mCherry plasmid DNA. Ef1a-driven, Flp recombinase-dependent expression of mCherry. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    mCherry (Flp-dependent)

    Available Since

    March 31, 2020

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-CAG-GFP (AAV6 trial size)

    Viral Prep

    #37825-AAV6.T

    Purpose

    Ready-to-use AAV6 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Promoter

    CAG

    Tags

    GFP

    Available Since

    July 16, 2025

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-hSynapsin- soCoChR-GFP (AAV9)

    Viral Prep

    #107708-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSynapsin- soCoChR-GFP (#107708). In addition to the viral particles, you will also receive purified pAAV-hSynapsin- soCoChR-GFP plasmid DNA. Synapsin-driven somatic CoChR (soCoChR) fused to GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Shemesh et al Nat Neurosci. 2017 Dec;20(12):1796-1806.

    Promoter

    Syn

    Tags

    GFP

    Available Since

    Sept. 7, 2018

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-S5E2-GFP-fGFP (AAV1)

    Viral Prep

    #135631-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Promoter

    Tags

    EGFP

    Available Since

    Sept. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

19. pAAV_hSyn-PdCO-mScarlet-WPRE (AAV5)

    Viral Prep

    #198510-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV_hSyn-PdCO-mScarlet-WPRE (#198510). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-mScarlet-WPRE plasmid DNA. Syn-driven expression of optimized PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Wietek et al Nat Methods. 2024 May 29. doi: 10.1038/s

    Promoter

    Syn

    Tags

    mScarlet

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-mDlx-NLS-mRuby2 (AAV1)

    Viral Prep

    #99130-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-mDlx-NLS-mRuby2 (#99130). In addition to the viral particles, you will also receive purified pAAV-mDlx-NLS-mRuby2 plasmid DNA. mDlx-driven NLS-mRuby2 expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

    Promoter

    mDLX5/6

    Tags

    mRuby2

    Available Since

    Jan. 14, 2019

    Availability

    Academic Institutions and Nonprofits only